MAT2A as key regulator and therapeutic target in MLLr Leukemogenesis
Similar content being viewed by others Introduction Hypertension (HTN) is the leading modifiable risk factor for cardiovascular disease (CVD) in the United States (U.S.) [1, 2] and globally [3]
The knowledge and professionalism is first in class
ROS may accumulate due to: Environmental toxins Inflammation Radiation exposure Aging Source: International Journal of Molecular Science Environmental Toxins / Drugs Certain toxins or drugs may damage mitochondria or inhibit respiratory chain enzymes, such as: Pesticides (e.g., rotenone, paraquat) Alcohol Antibiotics (e.g., chloramphenicol) Antiretrovirals (e.g., nucleoside reverse transcriptase inhibitors) Source: Current Environmental Health Reports Nutrient Deficiencies Mitochondrial function depends on cofactors and nutrients such as: Coenzyme Q10 (ubiquinone) B vitamins (especially B1, B2, B3, B5) L-carnitine Magnesium Alpha-lipoic acid Deficiencies may impair ATP production or increase oxidative burden
Taiwan J Ophthalmol
GLP-1 peptide Cagrilintide's changing clinical profile opens the door for new combination drugs that might have better patent protection, but they need bigger spending in clinical validation
